Cysteine Disulfides (Cys-ss-X) as Sensitive Plasma Biomarkers of Oxidative Stress.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 01 2019
Historique:
received: 22 06 2018
accepted: 06 11 2018
entrez: 16 1 2019
pubmed: 16 1 2019
medline: 30 1 2020
Statut: epublish

Résumé

We developed a high-throughput mass spectrometry-based method to simultaneously quantify numerous small-molecule thiols and disulfides in blood plasma. Application of this assay to analyze plasma from patients with known oxidative stress (sickle cell disease and sepsis) and from a patient with sickle cell disease treated with the antioxidant N-acetylcysteine suggests that cysteine disulfides, in particular protein-bound cysteine, serve as sensitive plasma biomarkers for the extent of oxidative stress and effectiveness of antioxidant treatment.

Identifiants

pubmed: 30643157
doi: 10.1038/s41598-018-35566-2
pii: 10.1038/s41598-018-35566-2
pmc: PMC6331564
doi:

Substances chimiques

Antioxidants 0
Biomarkers 0
Disulfides 0
Cysteine K848JZ4886
Acetylcysteine WYQ7N0BPYC

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL112633
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL117639
Pays : United States
Organisme : NHLBI NIH HHS
ID : R34 HL128798
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : HL112633
Pays : International

Références

Clin Chem. 2006 Jul;52(7):1406-14
pubmed: 16690733
Redox Rep. 2009;14(3):115-24
pubmed: 19490753
Biochim Biophys Acta. 2014 Feb;1840(2):838-46
pubmed: 23567800
Biochemistry. 1964 Apr;3:480-2
pubmed: 14192894
Anal Biochem. 2011 Aug 1;415(1):81-3
pubmed: 21545786
Clin Chem. 2006 Apr;52(4):601-23
pubmed: 16484333
Oxid Med Cell Longev. 2018 Feb 14;2018:2468457
pubmed: 29636836
Nat Protoc. 2006;1(6):3159-65
pubmed: 17406579
Altern Med Rev. 1998 Apr;3(2):114-27
pubmed: 9577247
Biochem Pharmacol. 1966 Oct;15(10):1523-35
pubmed: 5971807
Biochem Pharmacol. 2000 Jul 1;60(1):19-29
pubmed: 10807941
Biochem Pharmacol. 1989 Nov 15;38(22):3981-5
pubmed: 2597179
Eur J Clin Pharmacol. 1989;36(2):127-31
pubmed: 2721538
Clin Chem. 2002 May;48(5):742-53
pubmed: 11978601

Auteurs

Xiaoyun Fu (X)

Bloodworks Research Institute, Seattle, Washington, USA. xiaoyunf@bloodworksNW.org.
Department of Medicine, University of Washington, Seattle, Washington, USA. xiaoyunf@bloodworksNW.org.

Shelby A Cate (SA)

Bloodworks Research Institute, Seattle, Washington, USA.

Melissa Dominguez (M)

Bloodworks Research Institute, Seattle, Washington, USA.

Warren Osborn (W)

Bloodworks Research Institute, Seattle, Washington, USA.

Tahsin Özpolat (T)

Bloodworks Research Institute, Seattle, Washington, USA.

Barbara A Konkle (BA)

Bloodworks Research Institute, Seattle, Washington, USA.
Department of Medicine, University of Washington, Seattle, Washington, USA.

Junmei Chen (J)

Bloodworks Research Institute, Seattle, Washington, USA.

José A López (JA)

Bloodworks Research Institute, Seattle, Washington, USA. JoseL@bloodworksNW.org.
Department of Medicine, University of Washington, Seattle, Washington, USA. JoseL@bloodworksNW.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH